This transcript has been edited for clarity. Carolyn A. Chan, MD: Welcome. I'm Dr Carolyn Chan. I'm joined by my good friend and co-host, Dr Natalie Stahl. Natalie, how are you doing today? Natalie ...

Rising stimulant use is driving a new trend in national overdose deaths. While no medication has been FDA-approved for stimulant addiction, a handful demonstrate off-label evidence. These include ...

Prescription stimulant misuse was less prevalent among women aged 35 to 64, but this same group saw an increase in the number of individuals dispensed these medications. Among patients prescribed ...

Veterans with homelessness had higher rates of stimulant prescriptions, despite having a psychotic disorder or active cocaine use disorder.

However, patients who received their initial stimulant prescription through telehealth were at a higher risk of developing a stimulant use disorder after adjusting for other factors. Stimulant use ...

Stimulant use disorder involves drugs such as prescription medications, cocaine or methamphetamine, among other drugs. Patients aged 26 years and above who received an initial stimulant prescription ...

Psychostimulants, including amphetamine-type stimulants and methylphenidate, are most often prescribed to treat attention-deficit/hyperactivity disorder (ADHD). In ...

Stimulants, primarily amphetamines and methylphenidate, are increasingly prescribed to treat attention-deficit/hyperactivity disorder (ADHD) in adults — raising ...

About one in six working adults in the U.S. battle a substance use disorder, and nearly 10% of U.S. employees have a cannabis or stimulant use disorder. Recognizing this, Carrum Health has expanded ...